
Chemcrux Enterprises Q4 FY26 Results: PAT of Rs 1.84 crore Specialty Chemicals - Benzimidazoles
Updated: 15 May 2026 • 3:12 pm
Posted by:

Chemcrux Enterprises Q4 results were announced on May 14, 2026, at the company's board meeting. the company net profit increased to Rs 1.84 crore. The company manufactures specialty chemicals including benzimidazole derivatives used in pharmaceuticals, agrochemicals, and polymer applications. Investors tracking the company will find complete financial data, analysis, and FY27 outlook in this article.
Click Here – Get Free Investment Predictions
Chemcrux Enterprises Q4 FY26 Key Financial Highlights
| Metric | Q4 FY26 | Comparison |
|---|---|---|
| PAT (Net Profit) | Rs 1.84 crore | Q4 FY25 / Reference |
| Ticker | CHEMCRUX | Sector: Specialty Chemicals – Benzimidazoles |
Screen the best stocks on the Univest Screener.
Chemcrux Enterprises Performance Analysis
The company results reflect the company's operational performance during the January to March 2026 quarter. the company net profit increased to Rs 1.84 crore. The company manufactures specialty chemicals including benzimidazole derivatives used in pharmaceuticals, agrochemicals Investors and analysts monitoring the company results will focus on FY27 revenue guidance, margin trajectory, and management commentary on business outlook.
The company performance positions the company for FY27. Track the company analyst ratings and live stock price on the Univest Screener for real-time investment insights.
Chemcrux Enterprises FY27 Outlook
Post Chemcrux, investor focus for FY27 will be on revenue growth momentum, margin expansion, new order wins, and sector-specific tailwinds in the Specialty Chemicals – Benzimidazoles space. The Chemcrux results demonstrate the company's execution capabilities. Track Chemcrux updates on the Univest Screener for analyst views and FY27 earnings estimates.
Download the Univest iOS App or the Univest Android App to track live price and Q4 FY26 earnings updates.
Frequently Asked Questions on Chemcrux Enterprises Q4 FY26 Results
What is it PAT?
Ans. Chemcrux profit after tax was Rs 1.84 crore.
When did Chemcrux Enterprises announce Q4 FY26 results?
Ans. the company results were announced on May 14, 2026, at the company's board meeting and filed with BSE and NSE.
What is the FY27 outlook for Chemcrux Enterprises?
Ans. Post the company results, investors will track FY27 guidance and growth strategies in the Specialty Chemicals – Benzimidazoles sector. Track live updates on the Univest Screener.
Where can I track the company live data?
Ans. Track the company live stock price, analyst ratings, and earnings updates on the Univest Screener for real-time investment data.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered advisor before making any investment decision.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Nifty IT Today: Index Ends 0.47% Lower at 30,695.15
Nifty Pharma Today: Index Falls 0.68% to 26,478.10
Nifty Financial Services Today: Index Rises 0.49% at Close
Nifty Metal Today Rises 1.07% to 13,317.45: Closing Bell
Nifty Mid Select Today: Index Performance, Stocks & Breadth

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





